These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19758639)

  • 41. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laxative abuse, eating disorders, and kidney stones: a case report and review of the literature.
    Leaf DE; Bukberg PR; Goldfarb DS
    Am J Kidney Dis; 2012 Aug; 60(2):295-8. PubMed ID: 22560842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis.
    Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
    Urology; 2012 Oct; 80(4):780-3. PubMed ID: 22921695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED; Heller HJ; Adams-Huet B; Brinkley LJ; Pak CY; Pearle MS
    J Urol; 2006 Jul; 176(1):132-6. PubMed ID: 16753387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary reference values for stone risk factors in children.
    Borawski KM; Sur RL; Miller OF; Pak CY; Preminger GM; Kolon TF
    J Urol; 2008 Jan; 179(1):290-4; discussion 294. PubMed ID: 18006021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease.
    Sas DJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2062-8. PubMed ID: 21737846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic heritability of urinary stone risk in identical twins.
    Monga M; Macias B; Groppo E; Hargens A
    J Urol; 2006 Jun; 175(6):2125-8. PubMed ID: 16697817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospects for dietary therapy of recurrent nephrolithiasis.
    Goldfarb DS
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):21-9. PubMed ID: 19095202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [LithoRisk: A software for calculating and visualising nephrolithiasis risk profiles].
    Marangella M; Petrarulo M; Daniele PG; Sammartano S
    G Ital Nefrol; 2002; 19(6):693-8. PubMed ID: 12508173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on the medical management of stone disease.
    Tracy CR; Pearle MS
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
    Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
    Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethnic differences in relative risk of idiopathic calcium nephrolithiasis in North America.
    Mente A; Honey RJ; McLaughlin JR; Bull SB; Logan AG
    J Urol; 2007 Nov; 178(5):1992-7; discussion 1997. PubMed ID: 17869305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.
    Saccomani MD; Pizzini C; Piacentini GL; Boner AL; Peroni DG
    J Urol; 2012 Aug; 188(2):566-70. PubMed ID: 22704115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical reduction of stone risk in a network of treatment centers compared to a research clinic.
    Lingeman J; Mardis H; Kahnoski R; Goldfarb DS; Lacy S; Grasso M; Scheinman SJ; Parks JH; Asplin JR; Coe FL
    J Urol; 1998 Nov; 160(5):1629-34. PubMed ID: 9783920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of physico-chemical and biochemical composition of urine in the genesis of combined nephrolithiasis and cholelithiasis].
    Neĭmark AI; Fidirkin AV; Savenko VI
    Urologiia; 2002; (2):37-40. PubMed ID: 12077822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is 24-hour urinary calcium a surrogate marker for dietary calcium intake?
    Toren PJ; Norman RW
    Urology; 2005 Mar; 65(3):459-62. PubMed ID: 15780355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A HindIII polymorphism of fibronectin gene is associated with nephrolithiasis.
    Onaran M; Yilmaz A; Sen I; Ergun MA; Camtosun A; Küpeli B; Menevşe S; Bozkirli I
    Urology; 2009 Nov; 74(5):1004-7. PubMed ID: 19616291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Artificial neural networks for assessing the risk of urinary calcium stone among men.
    Dussol B; Verdier JM; Le Goff JM; Berthezene P; Berland Y
    Urol Res; 2006 Feb; 34(1):17-25. PubMed ID: 16397774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.